当前位置: 首页 > 期刊 > 《青岛大学医学院学报》 > 20183
编号:13581487
内源性凝血在脓毒症凝血紊乱中的作用及研究进展(6)
http://www.100md.com 2018年6月1日 《青岛大学学报(医学版)》 20183
     [46]JUDGE H M, BUCKLAND R J, SUGIDACHI A A, et al. Relationship between degree of P2Y(12) receptor blockade and inhibition of P2Y(12)-mediated platelet function[J]. Thrombosis and Haemostasis, 2010,103(6):1210-1217.

    [47]HERAULT J P, PERRIN B, JONGBLOET C, et al. Effect of factor Ⅹa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats[J]. Thrombosis and Haemostasis, 2000,84(4):668-674.

    [48]MULLER F, GAILANI D, RENNE T. Factor Ⅺ and Ⅻ as antithrombotic targets[J]. Current Opinion in Hematology, 2011,18(5):349-355.

    [49]ZHANG H, LOWENBERG E C, CROSBY J R, et al. Inhibition of the intrinsic coagulation pathway factor Ⅺ by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk[J]. Blood, 2010,116(22):4684-4692.

    [50]KLEINSCHNITZ C, STOLL G, BENDSZUS M, et al. Targeting coagulation factor Ⅻ provides protection from patholo-

    gical thrombosis in cerebral ischemia without interfering with hemostasis[J]. Journal of Experimental Medicine, 2006,203(3):513-518.

    [51]XU Y M, CAI T Q, CASTRIOTA G, et al. Factor Ⅺ la inhibition by infestin-4: in vitro mode of action and in vivo antithrombotic benefit[J]. Thrombosis and Haemostasis, 2014,111(4):694-704., 百拇医药(温菲 唐雯 靳茜茜 王焕亮)
上一页1 2 3 4 5 6